Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostaglandin Inhibition to Prevent Breast Cancer

NCT01769625 is registered in ClinicalTrials.gov with Hartford Hospital as lead sponsor.

NCT NCT01769625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01769625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostaglandin Inhibition to Prevent Breast Cancer
Lead sponsor
Hartford Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2009
Completion date
November 30, 2016
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarker change linked to breast cancer